Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
15 May 2024 Job Information Organisation/Company Lunds universitet Department Faculty of Medicine, Department of Experimental Medical Science Research Field Medical sciences » Other Researcher
-
Faculty of Medicine, Department of Experimental Medical Science Lund University was founded in 1666 and is repeatedly ranked among the world’s top universities. The University has around 47 000
-
capacity.. Applicants should be willing to contribute to the highly collaborative, inter-disciplinary and collegiate environment at the University of Reading. The position is available on a part time (up to
-
infection.” In the lab of Gemma Atkinson in Lund University, Department of Experimental Medical Science. The project’s co-investigator is Andrea Fossati, Karolinska Institute, Stockholm. Specifically
-
Stephens at the University of Reading, in collaboration with Compass Pathways, a biotechnology company dedicated to innovations in mental health care, has revealed that psilocybin also has novel effects in
-
for Academic Purposes at NUIST-Reading Academy, Nanjing University of Information Science & Technology (NUIST), Jiangsu Province, People’s Republic of China. The expected start date is September 2024
-
planning, and data interpretation. Additionally, through collaboration with MRX Medical, the applicant will acquire expertise in drug discovery and stem cell biology, as well as a wider understanding of
-
applicants will receive comprehensive training in cutting-edge techniques spanning cell biology, biochemistry, microscopy, molecular biology, experimental design, and data analysis. Co-funded by MRX Medical, a
-
photographer/angiographer through fundus photograph and OCT reading centers. (Acceptable reading centers include University of Wisconsin, Duke University OCT Reading Center, Digital Angiography Reading Center
-
management, physical exercise, medication adherence, and more. Despite knowledge and information on progression of the disease, the number of patients entering end-stage kidney disease (ESKD) is increasing